+357 22 358 600

CONTACT@CSHG.ORG.CY

Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.

This is your Side Push Panel Sidebar!

Please add your sidebar widgets to this section from Appearance > Widgets (Side Push Panel Sidebar).